OTCBB ALERTS

[stockasaurus rex]

RBRM: announces new marketing partner

ReBuilder Medical Technologies, Inc. Announces New Marketing Partner
Company Commits a Minimum of $150,000 to Promote its Products Through New Sales Programs such as infomercials
Jul 24, 2007 10:13:00 AM
CHARLES TOWN, W.Va., July 24 /PRNewswire-FirstCall/ -- ReBuilder Medical Technologies, Inc. (Other OTC: RBRM), an emerging medical device manufacturer founded by world renowned medical device inventor David B. Phillips, Ph.D., today announced it has signed a marketing agreement with Rousseau Associates, LLC. Rousseau Associates' services have been engaged by ReBuilder Medical to develop an infomercial. ReBuilder Medical has committed a budget of $150,000 to this new sales program to promote ReBuilder.

(Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO )

"Rousseau has been involved with several sales, marketing and business process advisory positions. By utilizing Rousseau's video marketing supervisory expertise to develop new television programming promoting our existing line of products is another way we are aggressively looking to leverage our products to further enhance our sales," said David B. Phillips, CEO of ReBuilder Medical Technologies, Inc. "We are closely working with the Rousseau Associates to properly promote the ReBuilder with consumers all over the U.S."

About ReBuilder Medical Technologies, Inc.:

ReBuilder Medical Technologies, Inc. is an emerging medical device manufacturer of innovative technologies founded by world renowned medical device inventor David B. Phillips, Ph.D. ReBuilder Medical's flagship product is its FDA registered, ReBuilder System for treating peripheral neuropathy. Unlike current therapies for neuropathy (nerve disease) which focus on prescription drugs with powerful side effects, the ReBuilder System is a portable, battery powered medical product that provides a new non-surgical treatment which is non-invasive, has no side effects and can actually strengthen muscles while increasing blood flow.

ReBuilder Medical also manufactures the Phillips Molluscum Treatment system for treating the skin disease Molluscum Contagiosum which primarily affects children. This system uses its proprietary form of micronized amorphous silver ions to disable the molluscum virus without side effects. The company is currently performing research and development on a number of other products as well.

More information on ReBuilder Medical and its products can be found at: http://www.rebuildermedical.net

Safe Harbor: This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainty, including without limitation, the ability of the Company to successfully implement its turnaround strategy, changes in costs of raw materials, labor, and employee benefits, as well as general market conditions, competition and pricing. Although the Company believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this letter will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as representation by the Company or any other person that the objectives and plans of the Company will be achieved. In assessing forward-looking statements included herein, readers are urged to carefully read those statements. When used in the Annual Report on Form 10-K, the words "estimate," "anticipate," "expect," "believe," and similar expressions are intended to be forward-looking statements.

SOURCE ReBuilder Medical Technologies, Inc.